NR 4-5/2004

get MSIE 4.x or better from www.microsoft.com/ie

Wpływ preparatu Egb 761 na czynność siatkówki u dzieci i młodzieży z długo trwającą cukrzycą insulinozależną – doniesienie wstępne

Influence of Egb 761 on the function of the retina in children and adolescent with long lasting diabetes mellitus – preliminary report

Jadwiga Bernardczyk-Meller, Joanna Siwiec-Prościńska, Witold Stankiewicz1, Piotr Fichna1, Krystyna Pecold, Eugeniusz Korman1

Z Katedry i Kliniki Okulistyki Akademii Medycznej w Poznaniu
Kierownik: prof. dr hab. n. med. Krystyna Pecold
1 Z Kliniki Endokrynologii i Diabetologii Wieku Rozwojowego Akademii Medycznej w Poznaniu
Kierownik: prof. dr hab. n. med. Eugeniusz Korman

Summary: Purpose: Early detection of patological function of the retina, before anatomical changes, plays very important role in monitoring of visual complications in patients with diabetes mellitus. The aim of the study was the evaluation of anatomical and functional changes in visual organ in children and adolescents with long lasting diabetes mellitus type 1 and taking Egb 761 (Tanakan Beaufour Ipsen) as an adjuvant.
Materials and methods: Group consists of 15 patients, age between 11 and 19 years, with diabetes mellitus lasting 6-12 years. All patients had full ophthalmologic examination and color vision tests (Panel D 15 saturated and desaturated). The examination was done 3 times, every 3 months. Egb 761 was given: 1 tablet - 3 times a day, during 3 months.
Results: No diabetic retinopathy was found. The results of color vision test were better after therapy (25% of pathological results) and 3 months later (only 4 % of patients).
Conclusions: 1. Egb 761 seems to be good adjuvant in patient with long lasting diabetes mellitus. 2. Color vision tests are sensitive tests of the retinal function and are easy to perform.
Słowa kluczowe:  cukrzyca, retinopatia cukrzycowa, widzenie barwne, testy Panel D 15, Egb 761.
Key words: diabetes mellitus, diabetic retinopathy, color vision, Panel D 15 – test, Egb 761.



linia-lewa.gif (150 bytes)


Wydawca dwumiesięcznika medycznego "Klinika Oczna"
Oftal Sp. z o.o.

ul. Lindleya4, 02-005 Warszawa
Oddział: 03-709 Warszawa ul. Sierakowskiego 13 (Szpital)

tel./fax: (0-22) 670-47-40
centrala: (0-22) 618-84-85 wew. 52-45

e-mail: ored@okulistyka.com.pl